The FDA announced that it encourages companies to develop nonprescription naloxone drugs to help reduce opioid overdoses. Certain naloxone hydrochloride drug products may be “approvable as safe and effective for nonprescription use,” the agency explained in a draft Federal Register notice, Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use. FDA has…